VEGFA and cardiovascular disorder: Investigators have sought to implicate VEGF as part of the mechanism by which OSAS results in greater incidence of cardiovascular disease.22 Our results showed that the concentrations of VEGF were significantly higher in OSAS patients than in healthy controls and were decreased after 12 weeks of CPAP treatment.